Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02188290 · ClinicalTrials.gov registry record
Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
A clinical trial, sponsored by Kiadis Pharma.
- Completed
- Registry status
- 178
- Enrollment target
NCT02188290: Completed study, sponsored by Kiadis Pharma.
NCT02188290 is a clinical trial that has completed, run by Kiadis Pharma. The registered enrollment target is 178 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02188290 has completed, sponsored by Kiadis Pharma.
- COMPLETED
- Registry status
- 178 participants
- Enrollment target
Study Summary
Study CR-AIR-006 is a part of the ATIR clinical development plan and will provide control data for patients treated with ATIR in clinical studies (e.g. study CR-AIR-007).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-06 |
What the finished NCT02188290 record still lists
NCT02188290 is an observational study that tracks outcomes without assigning an intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02188290 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02188290 about?
NCT02188290 is a clinical study titled "Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation". Study CR-AIR-006 is a part of the ATIR clinical development plan and will provide control data for patients treated with ATIR in clinical studies (e.g. study CR-AIR-007).
What is the current status of trial NCT02188290?
This trial is currently completed. The enrollment target is 178 participants. The study started on 2014-09. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT02188290?
This trial is sponsored by Kiadis Pharma, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03642002 · 178 participants · NA
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- NCT04227847 · 178 participants · Phase 1
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
- NCT04855214 · 178 participants
Evaluating the Experience of Upper Limb Prosthesis Use
- NCT05391126 · 178 participants · NA
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia